Neurogene Inc. (NGNE) Return on equity 2018–2025
Neurogene Inc. (NGNE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-34.1%FY2025 · since FY2018: -43.5% → -34.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.1% | -9.9 pp |
| FY2024 | -24.2% | -4.7 pp |
| FY2023 | -19.5% | — |
| FY2018 | -43.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice